Professor and Class,
What leads demonstrate the ST depression?
I found that leads I, II, and V2 to V6 demonstrate ST depression. Acute Coronary
Syndrome or ACS is demonstrated on an EKG if ST depression is present in
...
Professor and Class,
What leads demonstrate the ST depression?
I found that leads I, II, and V2 to V6 demonstrate ST depression. Acute Coronary
Syndrome or ACS is demonstrated on an EKG if ST depression is present in six or
more leads.
Is Lorene Hypertensive per ACA 2017 Guidelines? Compare the ACA
guidelines to JNC 8 guidelines and discuss what treatment you recommend
for her BP and why.
Yes, Lorene is hypertensive per the guidelines. Lorene’s elevated blood pressure of
146/90 places her at stage 2 hypertension based on the American College of
Cardiology (ACC) 2017 guidelines. Essential (primary) hypertension ICD 10
(I10) would be one of Lorene’s secondary diagnose. The ACC/AHA recently lowered
the definition of hypertension to allow for earlier intervention in the high blood
pressure guidelines because complications can occur at lower blood pressure
numbers (Whelton, Carey & Aronow, 2018). The ACC/AHA defines normal blood
pressure as a systolic blood pressure less than 120 mmHg and a diastolic blood
pressure less than 80 mmHg, stage 1 hypertension is a systolic blood pressure 130-
139 mmHg or a diastolic blood pressure of 80-89 mmHg, and stage II hypertension
as a systolic blood pressure greater than or equal to 140 or a diastolic blood
pressure greater than or equal to 90 (Whelton, Carey, & Aronow, 2018). The ACC
2017 guidelines differ from the Eight Joint National Commision (JNC 8) guidelines in
the blood pressure classification, as well as blood pressure goal targets based on
age and comorbidities. Regardless of age and whether the patient has diabetes
and/or chronic kidney disease (CKD), the ACC 2017 guidelines recommend a blood
pressure goal of less than 130/90. For patients 60 years and older, JNC 8 guidelines
recommend pharmacologic treatment for blood pressure goal of less than 150/90.
The initial pharmacologic treatment for both guidelines is similar, which includes
thiazide diuretics, angiotensin-converting enzyme inhibitors (ACEI), angiotensin
receptor blockers (ARB), and calcium channel blockers (CCB) (Armstrong, 2014).
The ACC/AHA recommendations are based on a 10-year atherosclerotic
cardiovascular disease or ASCVD, risk calculator of 10-year risk or higher. In the
presence of BP >140/90 mmHg, even if ASCVD risk is <10%, antihypertensive
treatment is indicated with a goal of reaching <130/80 mmHg utilizing a two-drug or
fixed dose combination. The JNC-8 recommends pharmacological treatment to
maintain a goal blood pressure of less than 140/90 if diabetes is present and
recommends for the general population with no history of diabetes or chronic kidney
disease that are aged 60 or older initiate pharmacologic treatment if systolic BP is
greater than 150 mmHg or diastolic B
[Show More]